Simplifying Global Compliance
Woodcock: Submit PRO Measures Early, Use to Check Quality of Life
Clinical Trials Advisor
Drug trial sponsors developing patient-reported outcome (PRO) measures should seek FDA qualification for those tools prior to clinical trials and should use them to gauge quality of life, CDER Director Janet Woodcock advises.
To View This Article:
Subscribe To Clinical Trials Advisor
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing